Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bansal

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Indian Journal of Nephrology|August 8, 2024
Role of Induction in a Haplomatch, Related, Low-Risk, Living-Donor Kidney Transplantation with Triple Drug Immunosuppression: A Single-Center StudyPranaw K Jha, Shyam B Bansal, Reetesh Sharma, et al.
Journal of Clinical and Experimental Hepatology|October 28, 2025
Chronic Kidney Disease After Living-donor Liver Transplantation: Prevalence and PredictorsNarendra S Choudhary, Swapnil Dhampalwar, Neeraj Saraf, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 27, 2025
SGLT-2 Inhibitors Are Associated With Lower Mortality and Decompensation in Patients With MASH Cirrhosis and Type 2 DiabetesDo Han Kim, Donghyun Ko, Vincent L Chen, et al.
Hepatology (Baltimore, Md.)|September 20, 2016
Hepatitis C virus double-stranded RNA is the predominant form in human liver and in interferon-treated cellsArielle Klepper, Francis J Eng, Erin H Doyle, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 27, 2025
Multiparametric MRI for Diagnosing Clinically Significant Portal Hypertension and Predicting Liver DecompensationEfe Ozkaya, Octavia Bane, Enamul Bhuiyan, et al.
Gastroenterology|March 11, 2026
Clinical Care Pathway for the Risk Stratification and Management of Patients with Metabolic Dysfunction-Associated Steatotic Liver DiseaseFasiha Kanwal, Fernando Bril, Vincent Wai-Sun Wong, et al.
Digestive Diseases and Sciences|June 19, 2025
Identifying Environmental Factors Associated with Significant Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease/SteatohepatitisAlejandra Paredes-Marin, Julia Napoli, Vikram Sivakumar, et al.
Annals of Hepatology|March 13, 2026
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. citiesJeffrey V Lazarus, Trenton M White, Melina Manolas, et al.
The Journal of Pediatrics|June 20, 2020
Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York CityShubhi Kaushik, Scott I Aydin, Kim R Derespina, et al.
Nature Reviews. Gastroenterology & Hepatology|January 30, 2026
Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver diseaseJeffrey V Lazarus, Christopher J Kopka, Aina Nicolàs, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Indian Journal of Nephrology|August 8, 2024
Role of Induction in a Haplomatch, Related, Low-Risk, Living-Donor Kidney Transplantation with Triple Drug Immunosuppression: A Single-Center StudyPranaw K Jha, Shyam B Bansal, Reetesh Sharma, et al.
Journal of Clinical and Experimental Hepatology|October 28, 2025
Chronic Kidney Disease After Living-donor Liver Transplantation: Prevalence and PredictorsNarendra S Choudhary, Swapnil Dhampalwar, Neeraj Saraf, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 27, 2025
SGLT-2 Inhibitors Are Associated With Lower Mortality and Decompensation in Patients With MASH Cirrhosis and Type 2 DiabetesDo Han Kim, Donghyun Ko, Vincent L Chen, et al.
Hepatology (Baltimore, Md.)|September 20, 2016
Hepatitis C virus double-stranded RNA is the predominant form in human liver and in interferon-treated cellsArielle Klepper, Francis J Eng, Erin H Doyle, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 27, 2025
Multiparametric MRI for Diagnosing Clinically Significant Portal Hypertension and Predicting Liver DecompensationEfe Ozkaya, Octavia Bane, Enamul Bhuiyan, et al.
Gastroenterology|March 11, 2026
Clinical Care Pathway for the Risk Stratification and Management of Patients with Metabolic Dysfunction-Associated Steatotic Liver DiseaseFasiha Kanwal, Fernando Bril, Vincent Wai-Sun Wong, et al.
Digestive Diseases and Sciences|June 19, 2025
Identifying Environmental Factors Associated with Significant Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease/SteatohepatitisAlejandra Paredes-Marin, Julia Napoli, Vikram Sivakumar, et al.
Annals of Hepatology|March 13, 2026
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. citiesJeffrey V Lazarus, Trenton M White, Melina Manolas, et al.
The Journal of Pediatrics|June 20, 2020
Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York CityShubhi Kaushik, Scott I Aydin, Kim R Derespina, et al.
Nature Reviews. Gastroenterology & Hepatology|January 30, 2026
Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver diseaseJeffrey V Lazarus, Christopher J Kopka, Aina Nicolàs, et al.
Pageof 14